2024-09-23 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis Report

**Company Overview:** CVS Health Corp is a healthcare company that operates retail pharmacies, pharmacy benefit management (PBM), and healthcare services. 

**Performance Analysis:**

**1.  Performance vs. S&P 500 (VOO):**

*   CVS has underperformed the S&P 500 significantly, with a cumulative return of -34.31% compared to 132.53% for the S&P 500. 
*   The current relative divergence of -166.84 indicates that CVS is significantly lagging behind the S&P 500, placing it at the 0.11 percentile of its historical performance relative to the index.

**2.  Recent Price Movement:**

*   Closing price: $57.51
*   5-day moving average: $58.05
*   20-day moving average: $57.71
*   60-day moving average: $58.22

The recent price movement suggests a slight downward trend, as the closing price is below the 5-day, 20-day, and 60-day moving averages.

**3.  Technical Indicators:**

*   RSI: 51.25:  This suggests that CVS is neither overbought nor oversold, with the stock currently trading at a neutral level.
*   PPO: 0.17: A positive PPO indicates a bullish momentum, but the current value is relatively low, suggesting a weak bullish momentum.
*   Delta_Previous_Relative_Divergence: -2.78: The negative value indicates a short-term downward trend in the relative divergence of the stock.
*   Expected Return: 14.57%:  This indicates a potential maximum 5-year expected return of 14.57% on current investments.

**4.  Recent Earnings & Outlook:**

| Date      | EPS   | Expected EPS |
| ---------- | ----- | ------------ |
| 2024-08-07 | 1.83  | 1.73         |
| 2024-05-01 | 1.31  | 1.7          |
| 2024-02-07 | 2.12  | 2.01         |
| 2023-11-01 | 2.21  | 2.13         |
| 2023-08-02 | 2.21  | 2.12         |

The most recent earnings for the quarter ending August 7th, 2024, came in at $1.83, exceeding the expected EPS of $1.73. This is a positive sign, indicating the company is performing better than anticipated. However, the overall trend in earnings suggests a decline in recent quarters, with the most recent earnings being the lowest since November 2023.

**5.  Overall Analysis:**

CVS Health Corp has experienced a significant underperformance compared to the S&P 500, and while the most recent earnings exceeded expectations, the overall trend suggests a potential slowdown in growth. Technical indicators provide a mixed picture, with a neutral RSI and a positive PPO indicating potential upside, but the negative divergence and recent price movement suggest caution. Investors should monitor the company's performance closely, particularly as the stock's long-term underperformance and recent downward trend may continue to weigh on its future performance. 

**6.  Recommendation:**

The data suggests a cautious approach to CVS at this time. Investors should continue to monitor the company's performance, particularly its earnings and the broader healthcare market, before making any investment decisions.